A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment

OBJECTIVE: Current type 2 diabetes (T2D) management contraindicates intensive glycemia treatment in patients with high cardiovascular disease (CVD) risk and is partially motivated by evidence of harms in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Heterogeneity in response...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Mariam, Arshiya, Miller-Atkins, Galen, Pantalone, Kevin M., Zimmerman, Robert S., Barnard, John, Kattan, Michael W., Shah, Hetal, McLeod, Howard L., Doria, Alessandro, Wagner, Michael J., Buse, John B., Motsinger-Reif, Alison A., Rotroff, Daniel M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2021
Assuntos:
Cardiovascular and Metabolic Risk
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247498/
https://ncbi.nlm.nih.gov/pubmed/33863751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-2700
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados